Vertex Pharmaceuticals Inc / Ma

Rockefeller Capital Management L.P. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/16/2026

Shares

135,232

Value ($000)

61,309

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/16/2026	61,309	0.1%	135,232	12/31/2025
2025 Q3	11/14/2025	36,350	0.1%	92,814	9/30/2025
2025 Q2	8/8/2025	44,387	0.1%	99,700	6/30/2025
2025 Q1	5/14/2025	44,101	0.1%	90,964	3/31/2025
2024 Q4	2/13/2025	39,784	0.1%	98,789	12/31/2024
2024 Q3	11/14/2024	32,808	0.1%	70,549	9/30/2024
2024 Q2	8/12/2024	33,351	0.1%	71,161	6/30/2024
2024 Q1	5/14/2024	29,211	0.1%	69,881	3/31/2024
2023 Q4	2/14/2024	24,627	0.1%	60,525	12/31/2023
2023 Q3	11/14/2023	18,393	0.1%	52,890	9/30/2023
2023 Q2	8/14/2023	18,096	0.1%	51,423	6/30/2023
2023 Q1	5/16/2023	14,406	0.1%	45,728	3/31/2023
2022 Q4	3/6/2023	13,729	0.1%	47,544	12/31/2022
2022 Q3	11/2/2022	13,835	0.1%	47,785	9/30/2022
2022 Q2	8/12/2022	12,107	0.1%	42,967	6/30/2022
2022 Q1	5/13/2022	9,636	0.0%	36,928	3/31/2022
2021 Q4	2/14/2022	6,614	0.0%	30,121	12/31/2021
2021 Q3	11/12/2021	4,329	0.0%	23,873	9/30/2021
2021 Q2	8/10/2021	3,507	0.0%	17,396	6/30/2021
2021 Q1	5/11/2021	4,027	0.0%	18,742	3/31/2021
2020 Q4	2/12/2021	2,728	0.0%	11,551	12/31/2020
2020 Q3	11/13/2020	2,980	0.0%	10,952	9/30/2020
2020 Q2	8/12/2020	3,048	0.0%	10,500	6/30/2020
2020 Q1	5/12/2020	1,955	0.0%	8,218	3/31/2020
2019 Q4	2/7/2020	488	0.0%	2,231	12/31/2019